Article
The influence of NAT2 genotypes on the plasma concentration of isoniazid and acetylisoniazid in Chinese pulmonary tuberculosis patients.
Clinica chimica acta; international journal of clinical chemistry - 1 Mar 2006
Chen Bing, Li Jin-Heng, Xu Yi-Min, Wang Jie, Cao Xiao-Mei
Abstract excerpt
BACKGROUND: Isoniazid (INH) is widely used in the therapy of tuberculosis. Poor metabolizer (PM) of the NAT2 is an important reason of inter-individual difference of the plasma INH concentration. We studied the relationship between NAT2 genotype and INH and its metabolite acetylisoniazid (AcINH) concentration in Chinese people. METHOD: Forty-six tuberculosis patients were enrolled in the study. Each patient took...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
